In this paper, we provided more evidence about whether IL-6/gp130/STAT3 signaling was activated in TAC mice and the cardioprotective mechanism of raloxifene on pressure overload-induced cardiac hypertrophy and HF. The gene discussed is STAT3; the disease is persistent truncus arteriosus.